Ray Nimrod, Matt Robson, and Zach Summers of Quinn Emanuel persuaded the Patent Trial and Appeal Board that their client, the Broad Institute, invented the use of the gene-editing technology CRISPR-Cas9 in plants and animals before two scientists who won the Nobel Prize in 2020 for work on it.
March 04, 2022 at 07:30 AM
9 minute read
Editor/columnist
What’s more valuable: a patent or a Nobel Prize?
In 2020 Jennifer Doudna from the University of California at Berkeley was awarded the Nobel Prize in chemistry alongside colleague Emmanuelle Charpentier from the University of Vienna for their work developing CRISPR-Cas9, a genome editing breakthrough that has revolutionized biomedicine. Aside from the scientific bragging rights, the Nobel win grants Doudna access to special free parking on the Berkeley campus.
Presented by BigVoodoo
Join the industry's top owners, investors, developers, brokers & financiers at THE MULTIFAMILY EVENT OF THE YEAR!
Law firms & in-house legal departments with a presence in the middle east celebrate outstanding achievement within the profession.
The premier educational and networking event for employee benefits brokers and agents.
Atlanta s John Marshall Law School is seeking to hire one or more full-time, visiting Legal WritingInstructors to teach Legal Research, Anal...
Lower Manhattan firm seeks a premises liability litigator (i.e., depositions, SJ motions, and/or trials) with at least 3-6 years of experien...
Join the Mendocino County District Attorney s Office and work in Mendocino County home to redwoods, vineyards and picturesque coastline. ...
MELICK & PORTER, LLP PROMOTES CONNECTICUT PARTNERS HOLLY ROGERS, STEVEN BANKS, and ALEXANDER AHRENS
(L-R) Ray Nimrod, Matt Robson, and Zach Summers of Quinn Emanuel. Courtesy photos
